PCSK7 and breast cancer: The fact that experimental expression of different forms of CASC4 (WT, AA65/66 or 5REL) leads to different/opposing biological consequences in the context of breast cancer, suggests that this protein might have dual actions depending on the associated activity of PC7/Furin.